Table 2 Description of secondary outcomes.
Outcome | Patients (N = 24) |
|---|---|
Survival, no. (%) | 24 (100) |
Median time to engraftment, days (range) | |
• Neutrophils | 14 (10–25) |
• Platelets | 18 (10–38) |
Graft failure, no. (%) | 0 (0) |
Acute GVHD, no. (%) | |
• Grade I | 3 (13) |
• Grade II | 8 (33) |
• Grade III-IV | 0 (0) |
Chronic GVHD, no. (%) | |
• Mild | 7 (29) |
• Moderate | 3 (13) |
• Severe | 0 (0) |
Viral reactivation, no. (%) | |
• CMV | 1 (4) |
• EBV | 1 (4) |
